Antioxidant Properties of Zinc and Copper-Blood Zinc-to Copper-Ratio As a Marker of Cancer Risk BRCA1 Mutation Carriers

Pathogenic mutations in BRCA1 (BReast CAncer gene 1) confer high risks of both breast (up to 70%) and ovarian (up to 40%) cancers. Zinc (Zn) and copper (Cu) are essential for various physiological functions, including antioxidant reactions. Their balance, reflected in the Zn/Cu ratio, plays a crucial role in maintaining redox homeostasis, which is vital for cancer prevention. This study examines the antioxidant properties of Zn and Cu, specifically focusing on the blood Zn/Cu ratio as a potential marker for cancer risk among BRCA1 mutation carriers. The study cohort consisted of 989 initially unaffected women, followed up for 7.5 years. Blood samples were analyzed using inductively coupled plasma mass spectrometry. Although individual Zn and Cu levels did not significantly correlate with overall cancer risk, those women with a Zn/Cu ratio above 6.38 experienced a significantly lower cancer risk than women with a ratio below this cut-off point. This suggests that the Zn/Cu ratio may be a valuable biomarker for cancer prevention in this high-risk group. Given the increased cancer risk in BRCA1 mutation carriers, optimizing Zn and Cu levels through dietary and active interventions could provide a preventive strategy.

Citing Articles

Exploration of the Prognostic Markers of Multiple Myeloma Based on Cuproptosis-Related Genes.

Gao X, Yuan J, Zhang X, Wang R, Yang J, Li Y Cancer Rep (Hoboken). 2025; 8(3):e70151.

PMID: 40042106 PMC: 11880913. DOI: 10.1002/cnr2.70151.

Relationships between blood cadmium concentration and risk of nine cancers: evidence from the NHANES 1999-2018 and Mendelian randomization analyses.

Wang J, Deng S, Cheng G, Wang Y, Shen Y, Chen J Discov Oncol. 2024; 15(1):823.

PMID: 39709583 PMC: 11663828. DOI: 10.1007/s12672-024-01692-9.

Comprehensive Mendelian randomization analysis of low-density lipoprotein cholesterol and multiple cancers.

Liang H, Tang C, Sun Y, Wang M, Tong T, Gao Q Discov Oncol. 2024; 15(1):798.

PMID: 39692937 PMC: 11655734. DOI: 10.1007/s12672-024-01684-9.

Coffee and Risk of Pancreatic Cancer: Insights from Two-Sample and Multivariable Mendelian Randomization Analyses.

Lu Y, Wang P, Liu H, Li T, Wang H, Jiang D Nutrients. 2024; 16(21).

PMID: 39519563 PMC: 11547416. DOI: 10.3390/nu16213723.

Dietary Interventions for Cancer Prevention: An Update to ACS International Guidelines.

Torres A, Quintanilla F, Barnafi E, Sanchez C, Acevedo F, Walbaum B Nutrients. 2024; 16(17).

PMID: 39275213 PMC: 11396961. DOI: 10.3390/nu16172897.

References

Urso E, Maffia M . Behind the Link between Copper and Angiogenesis: Established Mechanisms and an Overview on the Role of Vascular Copper Transport Systems. J Vasc Res. 2015; 52(3):172-96. DOI: 10.1159/000438485. View

Gurer-Orhan H, Ince E, Konyar D, Saso L, Suzen S . The Role of Oxidative Stress Modulators in Breast Cancer. Curr Med Chem. 2017; 25(33):4084-4101. DOI: 10.2174/0929867324666170711114336. View

Fischer P, Giroux A, LAbbe M . The effect of dietary zinc on intestinal copper absorption. Am J Clin Nutr. 1981; 34(9):1670-5. DOI: 10.1093/ajcn/34.9.1670. View

Stepien M, Hughes D, Hybsier S, Bamia C, Tjonneland A, Overvad K . Circulating copper and zinc levels and risk of hepatobiliary cancers in Europeans. Br J Cancer. 2017; 116(5):688-696. PMC: 5344297. DOI: 10.1038/bjc.2017.1. View

Pan H, He Z, Ling L, Ding Q, Chen L, Zha X . Reproductive factors and breast cancer risk among BRCA1 or BRCA2 mutation carriers: results from ten studies. Cancer Epidemiol. 2013; 38(1):1-8. DOI: 10.1016/j.canep.2013.11.004. View

Martin S, McVey M . BRCA1 protects against its own fragility. Mol Cell. 2022; 82(20):3757-3759. PMC: 10035668. DOI: 10.1016/j.molcel.2022.09.023. View

Ayala A, Munoz M, Arguelles S . Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 2014; 2014:360438. PMC: 4066722. DOI: 10.1155/2014/360438. View

Ghadirian P, Narod S, Fafard E, Costa M, Robidoux A, Nkondjock A . Breast cancer risk in relation to the joint effect of BRCA mutations and diet diversity. Breast Cancer Res Treat. 2009; 117(2):417-22. DOI: 10.1007/s10549-008-0292-y. View

Iqbal J, Ragone A, Lubinski J, Lynch H, Moller P, Ghadirian P . The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers. Br J Cancer. 2012; 107(12):2005-9. PMC: 3516682. DOI: 10.1038/bjc.2012.483. View

10.

Groelly F, Fawkes M, Dagg R, Blackford A, Tarsounas M . Targeting DNA damage response pathways in cancer. Nat Rev Cancer. 2022; 23(2):78-94. DOI: 10.1038/s41568-022-00535-5. View

11.

Patel D, Evanchuk J, Wang R, Dunbar C, Munhoz J, Field C . Regulation of immune function in healthy adults: one-stop guide on the role of dietary fatty acids, gut microbiota-derived short chain fatty acids, and select micronutrients in combination with physical activity. Appl Physiol Nutr Metab. 2023; 48(8):554-568. DOI: 10.1139/apnm-2022-0456. View

12.

Hellman N, Kono S, Mancini G, Hoogeboom A, de Jong G, Gitlin J . Mechanisms of copper incorporation into human ceruloplasmin. J Biol Chem. 2002; 277(48):46632-8. DOI: 10.1074/jbc.M206246200. View

13.

Gudmundsdottir K, Ashworth A . The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability. Oncogene. 2006; 25(43):5864-74. DOI: 10.1038/sj.onc.1209874. View

14.

Li X, You R, Wang X, Liu C, Xu Z, Zhou J . Effectiveness of Prophylactic Surgeries in BRCA1 or BRCA2 Mutation Carriers: A Meta-analysis and Systematic Review. Clin Cancer Res. 2016; 22(15):3971-81. DOI: 10.1158/1078-0432.CCR-15-1465. View

15.

Nkondjock A, Robidoux A, Paredes Y, Narod S, Ghadirian P . Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians. Breast Cancer Res Treat. 2006; 98(3):285-94. DOI: 10.1007/s10549-006-9161-8. View

16.

Bengtsson Y, Demircan K, Vallon-Christersson J, Malmberg M, Saal L, Ryden L . Serum copper, zinc and copper/zinc ratio in relation to survival after breast cancer diagnosis: A prospective multicenter cohort study. Redox Biol. 2023; 63:102728. PMC: 10209876. DOI: 10.1016/j.redox.2023.102728. View

17.

Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H . ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science. 2008; 320(5876):661-4. DOI: 10.1126/science.1156906. View

18.

Malavolta M, Piacenza F, Basso A, Giacconi R, Costarelli L, Mocchegiani E . Serum copper to zinc ratio: Relationship with aging and health status. Mech Ageing Dev. 2015; 151:93-100. DOI: 10.1016/j.mad.2015.01.004. View

19.

Stepien M, Jenab M, Freisling H, Becker N, Czuban M, Tjonneland A . Pre-diagnostic copper and zinc biomarkers and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort. Carcinogenesis. 2017; 38(7):699-707. DOI: 10.1093/carcin/bgx051. View

20.

Maxwell K, Wubbenhorst B, Wenz B, De Sloover D, Pluta J, Emery L . BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers. Nat Commun. 2017; 8(1):319. PMC: 5567274. DOI: 10.1038/s41467-017-00388-9. View